Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monofer vs Oral Iron in Chemotherapy Induced Anaemia
NCT01145638Phase 3Completed
- Sponsor
- Pharmacosmos
- Start
- Oct 2010
- Primary completion
- Apr 2014
- Modality
- Inorganic Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ferric derisomaltose (2 arms), sponsored by Pharmacosmos. Primary endpoint: Change in Hb Concentration at 4 weeks. Started Oct 2010; status: completed.
02
Drugs
ferric derisomaltose
Beyond the preview
Go deeper on NCT01145638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01145638.